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ABSTRACT 
Any palpable breast tissue in men is abnormal except during: the neonatal period, adolescence 
and in elderly age. Gynecomastia in prepubertal children may be due to enhanced endogenous 
oestrogen production, drugs or unknown causes. After the onset of puberty gynecomastia may 
also be due to a deficiency of testosterone. Young men and boys are particularly sensitive to 
oestrogens and may develop gynecomastia from exposure to industrial oestrogen, to creams 
containing oestrogens, to antiandrogens or to unrecognized endocrine substances. Furthermore 
gynecomastia and others pubertal disorders in males and females may be due to ingestion of food 
containing oestrogens or oestrogen-like substances; many “epidemics” of gynecomastia among 
children have been described. Hormones ingested by meat can cause breast enlagement and other 
deleterious immediate or long term effects. In particular it is a common concern among 
paediatricians and endocrine specialists that environmental and dietary “contaminants” may 
interfere with the pubertal development. In the evaluation of all this data we can not ignore the 
toxic effects of contamination may be having both in the short term but, more particularly, in the 
long term in terms of morbidity, mortality and therefore social costs. 
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Any palpable breast tissue in men is abnormal except for three situations: 
1. The transient gynecomastia of the newborn; this condition is present in many newborns 
and it is probably due to maternal and/or placental oestrogens (1). 
2. The breast enlargement at puberty in boys: this phenomenon is a frequent (30-75%) 
occurrence in male adolescence; the exact cause is uncertain. It is presumably due to the 
fact that in boys, during the early stage of puberty, the plasma ratios of testosterone to 
estradiol and of adrenal androgens to estrone tend to be low. Gynecomastia usually 
resolves in 2-3 years. Pubertal gynecomastia starts on average between the age of 10 and 
12 years with a peak occurrence between ages 13 and 14 (2-5). 
3. Gynecomastia that occasionally occurs in elderly men (6). 
A confounding problem in the ascertain of gynecomastia and premature thelarche is that it may be 
difficult to distinguish true enlargement of breast tissue from lipomastia, in which the enlargement 
is due to adipose tissue. This condition is very common in overweight children. True glandular 
breast tissue can be defined from lipomastia by ultrasonography and generally mammography is 
not required in defining breast tissue. 
Causes of gynecomastia 
Gynecomastia may be due to: 
1. Endocrine disorders: 
− Deficiency of testosterone: when gynecomastia occurs as a consequence of failure of 
testosterone synthesis (or action), it is generally associated with elevations of plasma 
gonadotropin levels and may or may not be associated with a secondary rise in 
oestrogen secretion. 
− Increased oestrogen production: this alteration can result from increased testicular 
oestrogen secretion, from increased substrate for extraglandular formation, or from 
increased extraglandular aromatase itself. 
2. Drugs, foods and environmental factors by several different mechanisms. 
3. Unknown causes. 
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Gynecomastia and drugs 
Drugs can cause gynecomastia by several mechanisms. Oestrogens administrated to males can 
result in severe gynecomastia. Young men and boys are particularly sensitive to oestrogen and 
may develop gynecomastia from industrial oestrogen exposure or from exposure to dermal 
ointments containing oestrogens, which are sometimes used without being aware that the creams 
contain oestrogens. 
Gynecomastia has been described in children exposed to oestrogenic cream used by the child’s 
mother (7). Gynecomastia may also develop as the result of subtle environmental exposure to 
oestrogens, to antiandrogens, or to unrecognised endocrine substances. In particular 
gynecomastia has been described in children of workers in a DES manufacturing plant, due to 
absorbtion of DES from the fathers’ clothing (8). 
Gynecomastia has been observed in adolescents using anabolic steroids to enhance athletic 
performance. Anabolic steroids decrease testosterone production, decrease spermatogenesis and 
induce testicular atrophy; in this case gynecomastia results from an imbalance in the testosterone 
to estradiol ratio. Anabolic steroids may also induce other rare and severe side effects such as 
malignancies and thrombotic phenomena (9). 
Phyto-oestrogens present in marijuana can cause breast enlargement by stimulation of the 
oestrogen receptors. Amphetamine abuse has also been associated with gynecomastia although 
its mechanism is still unclear. Thus any adolescent male presenting gynecomastia should be 
questioned about the use of illicit drugs (4). 
Gynecomastia is also described as possible side effect of growth hormone (GH) therapy both in 
paediatric and in elderly patients as GH has specific receptors in the mammary tissue stimulating 
glandular proliferation (10-12). For this reason any patient treated with growth hormone should be 
monitored for breast disorders. 
Gynecomastia and food 
Gynecomastia and other pubertal disorders in males and females may be also due to ingestion of 
food containing oestrogens or oestrogen-like substances. Such agents may be derived from meat 
and dairy products from animals treated with oestrogenic implants or from fungal oestrogens and 
phyto-oestrogens in foods (6). 
Although the toxic effects of steroids in animals and man have been well documented, such 
substances are still largely used in numerous countries for growth promotion, as the laws are 
highly variable from country to country. 
The use of such substances for growth promotion has been banned in Italy since the ‘80s after an 
EC directive, which is also valid for other EU countries. In contrast, controlled use of such growth 
promoters is allowed in the USA, Canada and Latin America. 
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Even in countries in which use is banned, these substances are frequently used illegally, and more 
and more cases are being uncovered. Hormonal growth promoters allow a 20% increase in weight 
in treated animals, and therefore give a significant economical benefit. The use of such hormones 
as growth promoters is most advantageous in the veal and poultry markets (13). 
The effects of hormone ingestion through food may cause two types of toxic effects: immediate 
and long term. 
Immediate effects depend on the age and sex of the subject, and include precocious thelarche, 
precocious pubarche, precocious puberty, gynecomastia, abnormalities of the menstrual cycle, 
decreased sperm count, sterility, decreased sexual desire and fetal malformations. (2, 14-19). 
The main long-term effect, which is dependent on age and sex, but mainly on the dose and 
exposure time, is the carcinogenicity of these growth promoters. 
In the literature there are many evidences that oestrogens and androgens influence breast cancer 
risk. (20-22). 
In particular diethylstilbestrol (DES) has been shown to be carcinogenic both in animals and in 
man. Herbst’s observation in the 70’s of the high incidence of vaginal adenocarcinoma in 
adolescents born of mothers treated with DES during pregnancy is known worldwide (23). 
This observation was confirmed in the following years with studies proving the toxicity of DES (14, 
24, 25). 
In the 80’s there was a case of a young man exposed to DES in utero who developed malformations 
of the reproductive system and seminoma in later years (26). 
More recent studies have confirmed the toxic effects of DES on the male reproductive system (19). 
Despite such evidence there was a high concentration of DES in baby foods in Italy up to the ‘80s. 
This was revealed during quality controls and showed the inefficiency or absence of sufficiently 
rigorous food controls (27). Even though the use of DES in livestock rearing is strictly banned 
worldwide, this substance is still illegally used as growth promoter, as Swiss police recently 
revealed. 
Toxic effects related to growth promoters and their ingestion through contaminated meat has also 
been described in children. Most interesting are the reported cases of abnormal pubertal 
development such as precocious thelarche, gynecomastia, and precocious puberty, which 
occasionally resemble epidemics. 
In 1979 in Italy we described an epidemic of gynecomastia and thelarche in a large pediatric 
population. 213 boys aged 3-14 yrs and 110 girls aged 3-7 yrs were studied. Breast enlargement 
was present in 29% of boys and in 21% of girls aged 3-5 yrs, in 58% of boys aged 6-10 yrs and in 
67% of girls aged 6-7 yrs. Breast enlargement disappeared within 8 months and although 
oestrogenic contamination was not proven an accidental contamination of the meat was 
suspected as the cause of the outbreak. (2). 
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In the ‘80s in Italy isolated cases of pseudo-precocious puberty linked to contaminated meat 
ingestion were recorded (28). 
In Puerto Rico anomalous sexual development was a major public health problem in the ‘80s. In 
those years a total of over 10.000 cases of anomalous sexual development were documented by 
Perez Comas and by the Puertorican Department of Health Thelarche Survey, which were 
established as a consequence of the increasing health problem. The manifestations were variables: 
gynecomastia, premature thelarche, precocious puberty, polycystic ovaries. In particular Puerto 
Rico was found to have the highest incidence of pubertal disorders worldwide. In this outbreak the 
authors described an association with the consumption of poultry contaminated with oestrogens, 
as well as with environmental contamination caused by pharmaceutical industries producing 
estroprogestinics. Total serum oestrogens were high in more than 80% of subjects tested (males 
and females) (15, 17, 18). 
Conclusions 
It is a common concern among paediatricians and endocrine specialists that environmental and 
dietary “contaminants” may interfere with the pubertal development (29). In the 90’s more and 
more cases of advanced pubertal development are being registered especially in the female 
population. It is also a common finding among paediatricians that there is an increasing number of 
female patients in whom pubertal progression is noticed before the age of nine years, thus creating 
a tendential decrease in the age at menarche (30). 
Numerous authors around the world have noticed this decrease in age at menarche and it has 
been attributed to both genetic and environmental factors (31-34). Possible causes include 
environmental contamination, food contamination, increased prevalence of obesity and altered 
socioeconomic status. 
In the USA it has been demonstrated that in females a tendency of advanced pubertal 
development is linked with increasing prevalence of obesity (35). In males an increase in weight 
has a variable effect on pubertal development (36). An increase in fat mass with the subsequent 
increase in leptin secretion could be one of the factors causing hypothalamic activation and the 
early onset of pubertal changes (37, 38). 
One American study carried out on a very large sample population showed that about 60% black 
girls and 30% Caucasian girls show signs of puberty before the age of 9 years (39). 
In the evaluation of all this data we can not ignore the toxic effects that environmental and dietary 
contamination may have both in the short term but, particularly, in the long term for morbidity, 
mortality and therefore social costs. 
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Discussion 
Mike Joffe (London, UK) How did you measure fertility in your follow-up study? 
Giuseppe Chiumello (Milan, Italy) As parameters of fertility, we considered the regularity of 
menses, the occurrence of pregnancies and miscarriage, the number of conceived children and the 
recourse to a fertility-care unit. We also considered as a parameter of infertility a period larger than 
12 months of unprotected sexual intercourse without conceiving. 
Patrick Thonneau (Toulouse, France) How did you choose your controls, and can you be sure that 
the controls had not eaten the same food thereby being exposed to the same diet with oestrogen 
or diethylstilboestrol (DES)? What was your period of follow up? 
Giuseppe Chiumello We tried to ensure that our controls were as similar as possible to the exposed 
subjects. The case group came from a private school in the pre-metropolitan area from medium to 
high socio-economic levels families. Controls were recruited in private schools of Milan using the 
register of 1977. The cases: Controls ratio was about 1:3. Controls were between 3 and 13 years of 
age at that time (1977), and the social status, the age and sex distributions, and the geographical 
areas were similar between the cases and controls. We are not sure that they had not been 
exposed to a subtle contamination. Moreover, we know that they did not have accidental 
gynaecomastia (or other pubertal disorders) with a significant prevalence at that time. 
Anna-Maria Andersson (Copenhagen, Denmark) Was the breast enlargement in your children due 
to a single accident causing high level exposure or was there exposure over a longer time interval? 
It is important to know if a single episode of accidental exposure can have any effect. 
Giuseppe Chiumello Both possibilities were considered but we cannot achieve any conclusion. 
Peterson Myers (Virginia, USA) Both bisphenol A and nonylphenol are commonly used as 
surfactants in insecticide mixtures, and are labelled as inert ingredients. Many schools even 
nowadays have fairly aggressive pest control programmes, and I suspect that in 1979 this was even 
more common. Did you consider such compounds as the source of oestrogen in your study? 
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Giuseppe Chiumello We checked this possibility in the school, but we were unable to demonstrate 
it and we cannot exclude the possibility. We could not trace the meat because it had already been 
consumed and the Police Department was unable to investigate a sample from the provider of 
meat to the school. We assumed that the meat was the source of the contamination because 
everything else was checked. Subsequent samples of meat from that provider were free from 
oestrogens when tested by the Police Department. 
Jorma Toppari (Turku, Finland) Small testicular size of less than 12 ml is expected to be associated 
with decreased inhibin B and increased FSH levels. Do you have any hormone level data from your 
study of gynaecomastia in the Italian school? 
Giuseppe Chiumello There was no significant differences in inhibin B values although they were 
slightly higher in the control subjects. All the other hormone levels were normal, including FSH. 
James Huff (NIEHS, USA) You said that marijuana and amphetamine are oestrogenic and cause 
gynaecomastia. Do you know the mechanism of this effect, or is it simply an oestrogenic reaction? 
Our 2 year study on these agents (THC) suggested that they were somewhat protective against 
tumourigenicity, and were associated with reduced body weight, increased survival and reduced 
incidence of tumours compared to controls. 
Giuseppe Chiumello Your results are very interesting. We do not have any evidence about the long 
term effect of THC. 
Sabine de Muinck Keizer-Schrama (Rotterdam, The Netherlands) Did you follow up the girls in your 
20 year study? They had a similar problem to the boys having developed thelarche. 
Giuseppe Chiumello There was no difference between the exposed and control groups in final 
height, fertility and endocrine disorders. A slightly increased prevalence of acne and hirsutism was 
noted in exposed women. 
Howard Kulin (Hershey, USA) Some years ago, in a controlled experiment, we treated normal 
prepubertal boys and girls with small doses of clomiphene citrate for 1 week: this drug regularly 
produced breast development within a few days (Kulin et al., Pediat Res 1972;6:162-71). Thus, 
prepubertal breast is extremely sensitive to oestrogens and it only takes a short time to produce a 
noticeable effect. Such information suggests that exposure to oestrogens from meat and other 
foods in the USA are probably at a very low level. 
Giuseppe Chiumello There are other examples of induced gynaecomastia. Occasionally this occurs 
in children who ingest their mother’s oral contraceptive pill and I am sure that small quantities of 
oestrogen can induce gynaecoymastia. However, the situation is quite different in Turner’s 
syndrome and pituitary growth hormone deficiency in which oestrogen is given to induce puberty. 
In such circumstances, breast enlargement appears after weeks of treatment with a low dose of 
oestrogen. Probably our children received a high dose of oestrogen, or were exposed for a long 
time. 
Why did you give clomiphene to normal children? 
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Howard Kulin We were actually giving clomiphene as an anti-oestrogen in an attempt to stimulate 
gonadotrophins, but the breast is so sensitive that the weakly oestrogenic effect of this anti-
oestrogen became apparent. 
Andreas Daxenberger ( Freising-Weihenstephan, Germany) What is the oral dose of oestradiol-170 
necessary to cause gynaecomastia in children after acute or chronic administration? Is it possible 
that gynaecomastia can develop after ingestion of an implantation site of animals on one, two or 
three occasions? 
Giuseppe Chiumello I do not know the dose required. It may be possible that ingestion of an 
implantation site can cause gynaecomastia, but I do not know for sure. 
Unidentified Discussant According to your abstract gynaecomastia may occur in children exposed 
to oestrogen cream used by their parents. Would you please expand on that study. 
Giuseppe Chiumello Recently it was described that 3 prepubertal boys presented with 
gynaecomastia after an indirect exposure to a custom-compounded preparation of oestrogen 
cream used by each child’s mother. All 3 boys presented with gynaecomastia, elevated oestradiol 
levels, rapid changes in growth and advanced bone age. 
Jean-Pierre Bourguignon (Liège, Belgium) Is there any evidence that the incidence of 
cryptorchidism and hypospadias is changing in the region of Italy where oestrogenic growth 
enhancers are used? 
Giuseppe Chiumello We have no data available at present on cryptorchidism or hypospadias but 
we are studying the prevalence of gynaecomastia, precocious puberty and precocious thelarche 
because it is our impression that there has been an increase in the last few years. We have not been 
able to explain this so far, and at present we define it as being idiopathic. 
